1 ORGS · 14 ACTIVITIES ← all strategies ·
theory of action →

Repurposing Metabolic Therapies

By exploring and supporting the use of metabolic therapies like semaglutide for neuropsychiatric conditions, psychiatric outcomes improve, because metabolic dysregulation plays a significant role in mental health disorders and targeting it can yield faster, more effective treatments. This strategy involves leveraging existing metabolic treatments—originally developed for conditions like diabetes or obesity—and applying them to psychiatric disorders based on emerging biological evidence. It distinguishes itself from traditional psychiatric treatment approaches by prioritizing physiological mechanisms over purely symptom-based interventions, and from other research strategies by focusing specifically on drug repurposing rather than novel drug development.

1
orgs running it
14
activities of those orgs
5
clusters touched
who runs it

organizations running this strategy · 1

what it looks like in practice

activities of orgs running this strategy

A sample of programmatic activities from the orgs above. These are what the strategy looks like on the ground.

  • Advocacy for Psychiatric Care and Mental Health Policy ARIZONA PSYCHIATRIC SOCIETY
    advocacy
    Advocates for improved psychiatric care and mental health policy in Arizona, including participating in legislative events, submitting rule changes, and promoting destigmatized licensure questions for physicians seeking mental health care.
  • Advocacy for mental health policy reform ARIZONA PSYCHIATRIC SOCIETY
    advocacy
    Engages in state-level advocacy to reform mental health policies, including successful efforts to change physician licensure questions to reduce stigma around mental health care, submission of Mental Health Parity Rules to regulatory bodies, and participation in legislative events such as Mental Health Day at the Capitol and advocacy for telehealth legislation.
  • Advocacy for mental health policy reform ARIZONA PSYCHIATRIC SOCIETY
    advocacy
    Engages in state-level advocacy to reform mental health policies, including successful efforts to change physician licensure questions to reduce stigma around mental health care seeking, submission of Mental Health Parity Rules to regulatory bodies, and participation in legislative advocacy events such as Mental Health Day at the Capitol and telehealth legislation promotion.
  • Member Communication and Resource Sharing ARIZONA PSYCHIATRIC SOCIETY
    direct service
    Publishes quarterly newsletters featuring updates on outreach and member activities, member achievements, relevant resources, original content, and information on community partners and issues relevant to psychiatry.
  • Member engagement and recognition programs ARIZONA PSYCHIATRIC SOCIETY
    direct service
    Recognizes professional contributions through awards such as the Mental Health Public Service Award and Presidential Leadership Award, and highlights member achievements and activities in quarterly newsletters.
  • Member engagement and recognition programs ARIZONA PSYCHIATRIC SOCIETY
    direct service
    Recognizes professional and academic excellence through awards such as the Mental Health Public Service Award, Presidential Leadership Award, and scholarships for residents and medical students; also publishes quarterly newsletters highlighting member achievements, outreach, and relevant psychiatric resources.
  • Professional Development and Continuing Medical Education ARIZONA PSYCHIATRIC SOCIETY
    capacity building
    Supports psychiatrists and fosters professional development by providing educational resources such as conferences, workshops, webinars, and free monthly on-demand CME courses to help members meet licensure requirements.
  • Professional development and capacity building for psychiatrists ARIZONA PSYCHIATRIC SOCIETY
    capacity building
    Offers continuing medical education (CME) credits, conferences, workshops, webinars, and on-demand educational resources to support professional growth, maintain licensure, and disseminate knowledge on psychiatric research, treatment, and best practices.
  • Professional development and education for psychiatrists ARIZONA PSYCHIATRIC SOCIETY
    capacity building
    Provides continuing medical education (CME) credits, monthly on-demand CME courses, and educational events such as conferences, workshops, webinars, and a Poster Symposium to support professional growth and knowledge sharing among psychiatrists, residents, fellows, and medical students in Arizona.
  • Psychiatric Research Showcase and Awards ARIZONA PSYCHIATRIC SOCIETY
    direct service
    Hosts a Poster Symposium for Resident-Fellow Members, Medical Students, and Psychiatric Physicians to showcase their research and offers scholarship awards for participants in a judged competition.
  • Publication of Psychiatric Research ARIZONA PSYCHIATRIC SOCIETY
    research
    Publishes research on various psychiatric topics, including melatonin and sleep in schizophrenia, Arizona's Controlled Substances Prescription Monitoring Program, and medical student attitudes toward psychiatry.
  • Recognition and Awards ARIZONA PSYCHIATRIC SOCIETY
    direct service
    Presents awards such as the Mental Health Public Service Award and Presidential Leadership Awards to individuals for their contributions to mental health and psychiatry.
  • Support for psychiatric research ARIZONA PSYCHIATRIC SOCIETY
    research
    Conducts and publishes original research on psychiatric topics including antipsychotic side effects, sleep disorders in schizophrenia, telehealth, controlled substance monitoring, and novel applications of semaglutide in neurodegenerative diseases; also supports research dissemination through a resident-fellow poster symposium.
  • Support for psychiatric research and trainee development ARIZONA PSYCHIATRIC SOCIETY
    research
    Hosts a Poster Symposium for residents, fellows, medical students, and physicians to present research; provides small scholarships for trainees participating in judged competitions; and publishes original research on topics such as antipsychotic-induced side effects, sleep disorders in schizophrenia, and psychiatric applications of semaglutide.